PHARMACELSUS GMBH
Desconocido
TALENTS: Training AlliancE for Novel Microbiome-Modulating TherapieS
PHARMACELSUS GMBH
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2021-COFUND-01
TALENTS aims to build up an international programme for interdisciplinary and transsectorial training of 15 doctoral candidates (DCs) as nee...
2022-09-02 - 2027-12-31 | Financiado
2022-09-02 - 2027-12-31 | Financiado
NOFUN: Novel antifungals to treat resistant organisms
PHARMACELSUS GMBH
participó en un
FP7:
Invasive fungal diseases are estimated to kill 1.5 million people each year. The incidence of mortality has risen significantly across the E...
Financiado
Financiado
FLUCURE: Development of novel antiviral drugs against Influenza
PHARMACELSUS GMBH
participó en un
FP7:
Influenza viruses cause a highly contagious respiratory disease in both humans and animals. Typically, influenza spreads worldwide in season...
Financiado
Financiado
* No se disponen de datos de la empresa actual.